Emily Greenspahn, Ph.D.

Emily Greenspahn, Ph.D., is director of neuropsychological services at the Texas Child Study Center, a collaboration between Dell Children’s Medical Center and the College of Education of The University of Texas at Austin. She is also an assistant professor in the Department of Neurology and a courtesy assistant professor in the Department of Psychiatry and Behavioral Sciences at Dell Medical School. She is a licensed psychologist in the State of Texas.

Greenspahn received her Bachelor of Science degree in psychology from Tulane University. She then earned her Master of Arts and Doctor of Philosophy degrees in school psychology from UT Austin. Greenspahn completed a one-year predoctoral internship at Virginia Beach City Public School on the pediatric neuropsychology track. She then completed a two-year APPCN neuropsychology postdoctoral fellowship at Baylor College of Medicine. The major rotation of her fellowship was at The Institute for Rehabilitation and Research (TIRR), with additional rotations in neuropsychology at various hospitals in the Texas Medical Center in Houston including MD Anderson Cancer Center, Texas Children’s Hospital and the University of Texas-Houston Health Science Center.

Greenspahn specializes in pediatric neuropsychology. She developed and directs the Texas Child Study Center’s Embedded Behavioral Clinic in the Children’s Blood & Cancer Center at Dell Children’s Medical Center. Greenspahn’s specific areas of interest involve the neuropsychological assessment and treatment of children with medical issues that affect neurological functioning including brain tumors and other types of cancer, blood disorders, stroke, CNS infections and traumatic brain injury. Her foundational training in school psychology has enhanced her delivery of neuropsychological services by providing her with a fundamental understanding of the special education process and laws specific to Texas. Greenspahn also trains graduate students and predoctoral interns from UT Austin in neuropsychological assessment. She has research interests in evaluating neurocognitive functioning in neuro-oncology, cancer, and blood disorder patient populations over time.